Detalhe da pesquisa
1.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
N Engl J Med
; 387(2): 132-147, 2022 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35660812
2.
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA.
Blood
; 136(1): 71-80, 2020 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32244252
3.
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy.
Am J Hematol
; 97(9): 1170-1177, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35731911
4.
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Blood Cancer J
; 14(1): 69, 2024 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38649340
5.
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation.
EJHaem
; 4(3): 775-778, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37601885
6.
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial.
Lancet Haematol
; 10(11): e890-e901, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37776872
7.
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials.
Transplant Cell Ther
; 29(3): 174.e1-174.e10, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36494017
8.
Estradiol levels predict bone mineral density in male collegiate athletes: a pilot study.
Clin Endocrinol (Oxf)
; 76(3): 339-45, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21942923
9.
Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myeloma.
Haematologica
; 102(7): e261-e265, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28385778
10.
Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy - incidental or related?
Neuromuscul Disord
; 32(6): 533-538, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35550111
11.
Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma - The Oregon Health and Science University Experience.
Clin Lymphoma Myeloma Leuk
; 22(2): 105-112, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34686447
12.
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma.
J Clin Oncol
; 40(25): 2901-2912, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34898239
13.
Diagnosis of paraproteinemic neuropathy: Room for improvement.
J Neurol Sci
; 415: 116902, 2020 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32497875
14.
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR.
Clin Lymphoma Myeloma Leuk
; 20(8): 509-518, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32482541
15.
Modified HyperCVAD Versus Bortezomib-HyperCAD in Patients With Relapsed/Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 18(1): e77-e84, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29169873
16.
Bortezomib-based Chemotherapy for Multiple Myeloma Patients Without Comorbid Cardiovascular Disease Shows No Cardiotoxicity.
Clin Lymphoma Myeloma Leuk
; 18(12): 796-802, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30217616
17.
Pharmacokinetics and Exposure-Response Analyses of Daratumumab in Combination Therapy Regimens for Patients with Multiple Myeloma.
Adv Ther
; 35(11): 1859-1872, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30374808
18.
Autopsy among recipients of stem cell transplant for hematologic malignancies in the modern era.
Bone Marrow Transplant
; 56(1): 282-284, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32641800